Whether adiponectin exerts protective effect on glucose metabolism and neuronal functioning delaying the onset of metabolic and neurodegenerative diseases in middle-aged individuals remains poorly investigated. The gene discussed is ADIPOQ; the disease is neurodegenerative disease.